
CAS 61616-97-5
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 prodotti.
Ref: 4Z-S-0142
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta6,7-Dehydrohyoscyamine
CAS:Prodotto controllato<p>Stability Hygroscopic<br>Applications 6,7-Dehydrohyoscyamine is a derivative of Scopolamine (S200000), an acetylcholine antagonist. Used in treatment of motion sickness; antiemetic; antispasmodic; mydriatic; preanesthetic medicant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Brand, J.J., et al.: Lancet, 2, 232 (1970), Bowles, J.B., et al.: Anaesthesia, 34, 476 (1979), Clissold, S.P., et al.: Drugs, 29, 189 (1985), Muhtadi, F.J., et al.: Anal. Profiles Drug Subs., 19, 477 (1990),<br></p>Formula:C17H21NO3Colore e forma:NeatPeso molecolare:287.356,7-Dehydrohyoscyamine
CAS:<p>6,7-Dehydrohyoscyamine (6,7DHHA) is a synthetic alkaloid that is produced by the dehydration of hyoscyamine. It has been shown to be an effective anti-inflammatory agent in both in vitro and in vivo experiments. 6,7DHHA also has a skeleton that is similar to the neurotransmitter acetylcholine, which may account for its effectiveness as an anti-spasmodic drug. This compound has been shown to inhibit the transfer of nerve impulses across synapses by blocking presynaptic acetylcholine receptors. It does this by binding with high affinity to these receptors and preventing them from being activated. 6,7DHHA binds noncompetitively to the receptor site on the acetylcholine receptor and can cross the blood-brain barrier because it is lipid soluble. The biosynthesis of 6,7DHHA starts with two molecules of L-phenylalanine condensed together with one molecule of L-</p>Formula:C17H21NO3Purezza:Min. 95%Peso molecolare:287.35 g/molRef: ST-EA-CP-S114002
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta



